Abbonarsi

Long-term outcomes after endoscopic submucosal dissection for superficial colorectal tumors - 20/04/17

Doi : 10.1016/j.gie.2016.07.044 
Kenjiro Shigita, MD 1, Shiro Oka, MD, PhD 2, , Shinji Tanaka, MD, PhD 2, Kyoku Sumimoto, MD 1, Daiki Hirano, MD 1, Yuzuru Tamaru, MD 1, Yuki Ninomiya, MD 1, Naoki Asayama, MD 1, Nana Hayashi, MD, PhD 2, Fumio Shimamoto, MD, PhD 3, Koji Arihiro, MD, PhD 4, Kazuaki Chayama, MD, PhD 1
1 Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan 
2 Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan 
3 Department of the Faculty of Human Culture and Science, Prefectural University of Hiroshima, Hiroshima, Japan 
4 Department of Anatomical Pathology, Hiroshima University Hospital, Hiroshima, Japan 

Reprint requests: Dr. Shiro Oka, Hiroshima University Hospital, Endoscopy, 1-2-3 Kasumi, Minami-ku, Hiroshima 734 8551, Japan.Hiroshima University Hospital, Endoscopy1-2-3 KasumiMinami-kuHiroshima 734 8551Japan

Abstract

Background and Aims

Endoscopic submucosal dissection (ESD) is an effective procedure for en bloc resection of superficial colorectal tumors regardless of tumor size or location. However, there are few reports on long-term outcomes for patients with superficial colorectal tumors after ESD. We therefore aimed to evaluate the long-term outcomes after ESD for superficial colorectal tumors.

Methods

ESD was performed on 257 colorectal tumors in 255 consecutive patients at Hiroshima University Hospital between June 2003 and July 2010. We investigated the following variables: patient characteristics, the American Society of Anesthesiologists score, tumor location, tumor size, growth type, histology, en bloc resection rate, achievement of curative resection, procedure time, and adverse events. The 5-year overall survival (OS), 5-year disease-specific survival (DSS), local recurrence, and metachronous tumor occurrence were also analyzed.

Results

We identified 224 tumors in 222 patients who were confirmed dead or had follow-up data for more than 5 years. After a median follow-up of 79 months, 5-year OS and DSS rates were 94.6% and 100%, respectively. The local recurrence rate (1.5%) was significantly higher in patients undergoing piecemeal resection (9.1%) compared with en bloc resection (0.6%), in cases of histologic incomplete resection compared with complete resection, and in cases of non-R0 resection compared with R0 resection. The rates of total number of tumors (≥6 mm) and carcinoma metachronous tumors after ESD without additional surgical resection were 18.9% (38/201) and 4.0% (8/201), respectively.

Conclusions

Long-term outcomes after ESD for superficial colorectal tumors are favorable. Patients should be surveyed for both local recurrence and metachronous tumors after ESD.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : ASA, DSS, ESD, HMO, JSCCR, LST, OS, SD, SM, VMO


Mappa


 DISCLOSURE: This study was conducted with a Grant-in-Aid from the Japan Agency for Medical Research and Development, AMED (15ck0106102h0102). All authors disclosed no financial relationships relevant to this publication.


© 2017  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 85 - N° 3

P. 546-553 - marzo 2017 Ritorno al numero
Articolo precedente Articolo precedente
  • Effect of an endoscopic quality improvement program on adenoma detection rates: a multicenter cluster-randomized controlled trial in a clinical practice setting (EQUIP-3)
  • Michael B. Wallace, Julia E. Crook, Colleen S. Thomas, Estella Staggs, Laurie Parker, Douglas K. Rex
| Articolo seguente Articolo seguente
  • Colorectal endoscopic submucosal dissection in the United States: Why do we hear so much about it and do so little of it?
  • Douglas K. Rex, C. Cesare Hassan, John M. Dewitt

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.